Pharmacotherapy for Cardiovascular Disorders in the media piece
consider the impact of potential pharmacotherapeutics for cardiovascular disorders introduced in the media piece.
Select one the following factors: genetics, gender, ethnicity, age, or behavior factors. Reflect on how the factor you selected might influence the patient’s pharmacokinetic and pharmacodynamic processes.
Consider how changes in the pharmacokinetic and pharmacodynamic processes might impact the patient’s recommended drug therapy.
hink about how you might improve the patient’s drug therapy plan based on the pharmacokinetic and pharmacodynamic changes. Reflect on whether you would modify the current drug treatment or provide an alternative treatment option for the patient. Write a 2- to 3-page paper that addresses the following:
Explain how the factor you selected might influence the pharmacokinetic and pharmacodynamic processes in the patient from the case study you were assigned.
Describe how changes in the processes might impact the patient’s recommended drug therapy. Be specific and provide examples.
Explain how you might improve the patient’s drug therapy plan and explain why you would make these recommended improvements.
Sample Solution
Cardiovascular diseases (CVDs) remain the biggest cause of death worldwide. According to estimates in a report by the World Health organization in 2011, approximately 17.1 million people die of CVDs each year, representing 30% of all deaths. Even though a drug may have a significant role for curative, preventive, or diagnostic purposes, it may also have debilitating, negative effect on the health of patients if it is not used properly (Srikanth, 2017). Moreover, the availability of a wide range of drug products and drug consumers as well as complicated regimens of drugs can contribute to more adverse drug events (ADEs) and drug interactions that may create difficulty in the follow-up for the patients.
